Vor Biopharma Inc. (VOR) Latest Stock News & Headlines
Get the latest Vor Biopharma Inc. (VOR) stock news and headlines to help you in your trading and investing decisions.
Vor Bio Secures $55.6 Million in PIPE Financing, Shares Surge …
Dec 27, 2024 · Friday's private investment in public equity transaction valued at $55.6 million by Vor Biopharma Inc. (VOR, Financials) sent its stock price skyrocketing 46.78% to finish at $1.23. The funding...
VOR News Today | Why did Vor Biopharma stock go down today?
Dec 31, 2024 · Shares of Vor Biopharma Inc. (NYSE:VOR - Get Free Report) have been assigned a consensus rating of "Buy" from the six ratings firms that are presently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating.
Vor Biopharma (VOR) Stock Price, News & Analysis - MarketBeat
Jan 3, 2025 · Should You Buy or Sell Vor Biopharma Stock? Get The Latest VOR Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
VOR Stock Price | Vor Biopharma Inc. Stock Quote (U.S.: Nasdaq ...
3 days ago · VOR | Complete Vor Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Vor Bio Announces $55.6 Million Private Placement - Yahoo Finance
CAMBRIDGE, Mass., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it has entered into a securities purchase...
Vor Biopharma Inc. (VOR) Stock Price, Quote & News - Stock …
3 days ago · Get a real-time Vor Biopharma Inc. (VOR) stock price quote with breaking news, financials, statistics, charts and more.
Vor Biopharma Inc. (VOR) Latest Stock News - Seeking Alpha
Dec 19, 2024 · Get the latest news and real-time alerts from Vor Biopharma Inc. (VOR) stock at Seeking Alpha.
Promising Clinical Outcomes and Strategic Acquisitions Bolster …
Sep 5, 2024 · Vor Bio announces new data, plans to approach FDA on trial design by year-end; New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
Vor Bio Announces $55.6 Million Private Placement
CAMBRIDGE, Mass., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it has entered into a securities purchase...
- Some results have been removed